Quarterly Result7 May 2026, 12:40 pm
Indoco Remedies: FY26 Revenue ₹1633.54 Mn
AI Summary
Indoco Remedies Ltd's Board of Directors approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The board recommended a dividend of ₹0.20 per equity share, subject to shareholder approval. For the year ended March 31, 2026, the company's revenue from operations stood at ₹1633.54 million.
Key Highlights
- Indoco Remedies' board approved audited financial results for FY26.
- The board recommended a dividend of ₹0.20 per share, pending shareholder approval.
- FY26 revenue from operations reached ₹1633.54 million.
- Auditors issued an unmodified opinion on the audited financial results.